Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-01-17 @ 3:16 AM
Study NCT ID:
NCT01577459
Status:
COMPLETED
Last Update Posted:
2018-08-21
First Post:
2012-04-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response
Sponsor:
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Subjects | View |
Keywords: